Nigel A Rees Net Worth

The estimated Net Worth of Nigel A Rees is at least $5.68 millió dollars as of 21 May 2016. Nigel Rees owns over 2,079 units of Mckesson stock worth over $3,613,476 and over the last 21 years Nigel sold MCK stock worth over $2,064,840.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Nigel Rees MCK stock SEC Form 4 insiders trading

Nigel has made over 30 trades of the Mckesson stock since 2005, according to the Form 4 filled with the SEC. Most recently Nigel exercised 2,079 units of MCK stock worth $1,061,226 on 21 May 2016.

The largest trade Nigel's ever made was selling 21,000 units of Mckesson stock on 8 March 2012 worth over $1,817,340. On average, Nigel trades about 5,319 units every 96 days since 2003. As of 21 May 2016 Nigel still owns at least 7,079 units of Mckesson stock.

You can see the complete history of Nigel Rees stock trades at the bottom of the page.

What's Nigel Rees's mailing address?

Nigel's mailing address filed with the SEC is ONE POST STREET, , SAN FRANCISCO,, CA, 94104.

Insiders trading at Mckesson

Over the last 21 years, insiders at Mckesson have traded over $302,794,946 worth of Mckesson stock and bought 2,692 units worth $392,568 . The most active insiders traders include John H Hammergren, Andy D Bryant és Paul C Julian. On average, Mckesson executives and independent directors trade stock every 11 days with the average trade being worth of $16,550,831. The most recent stock trade was executed by Brian S. Tyler on 5 September 2024, trading 3,753 units of MCK stock currently worth $2,105,808.

What does Mckesson do?

mckesson corporation, currently ranked 11th on the fortune 500 list, is a healthcare services and information technology company dedicated to making the business of healthcare run better. we partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. mckesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. for more information, visit us at www.mckesson.com.

Complete history of Nigel Rees stock trades at Mckesson

Mckesson executives and stock owners

Mckesson executives and other stock owners filed with the SEC include:

• Brian Tyler,
  Chief Executive Officer, Director
• Lori Schechter,
  Executive Vice President, Chief Compliance Officer, General Counsel
• Britt Vitalone,
  Chief Financial Officer, Executive Vice President
• Tracy Faber,
  Chief Human Resource Officer, Executive Vice President
• Edward Mueller,
  Independent Chairman of the Board
• N. Anthony Coles,
  Independent Director
• Dominic Caruso,
  Independent Director
• Marie Knowles,
  Independent Director
• Bradley Lerman,
  Independent Director
• Donald Knauss,
  Independent Director
• Susan Salka,
  Independent Director
• Christine Jacobs,
  Independent Director
• Kenneth Washington,
  Independent Director
• Maria Martinez,
  Independent Director
• Linda Mantia,
  Independent Director
• Tom Rodgers,
  Executive Vice President and Chief Strategy and Business Development Officer
• Nancy Flores,
  Executive Vice President, Chief Technology Officer, Chief Information Officer
• Paul A. Smith,
  Sr. VP of Taxes
• Kirk Kaminsky,
  Pres of The US Pharmaceutical & Specialty Solutions Bus.
• Pete Slone,
  Sr. VP of Corp. Public Affairs
• Holly Weiss,
  Sr. VP of Investor Relations
• Nancy Flores,
  Exec. VP, Chief Information Officer & CTO
• Sundeep G. Reddy,
  Sr. VP, Principal Accounting Officer & Corp. Controller
• Le Ann B Smith,
  EVP & Chief HR Officer
• Michele Lau,
  EVP and Chief Legal Officer
• Webster Roy Dunbar,
  Director
• Kevin M Ozan,
  Director
• Wayne A Budd,
  Director
• Andy D Bryant,
  Director
• James A Beer,
  EVP & Chief Financial Officer
• Kathleen D Mcelligott,
  EVP, CIO & CTO
• John H Hammergren,
  Chairman, President & CEO
• Erin Brewer,
  SVP & Chief Accounting Officer
• Bansi Nagji,
  EVP, Corp Strategy & Bus. Dev.
• Patrick Blake,
  EVP
• Paul C Julian,
  Senior Vice President
• Nigel A Rees,
  Vice President & Controller
• James H. Hinton,
  Director
• Kathleen Wilson Thompson,
  Director
• Sundeep G. Reddy,
  SVP & Controller
• Marc E Owen,
  SVP, Corporate
• Jorge Figueredo,
  EVP, Human Resources
• Cheryl T/Ca Smith,
  SVP & CIO
• Ivan D Meyerson,
  SVP, General Counsel
• Richard F/Ca Syron,
  Director
• James V Napier,
  Director
• Graham O King,
  Senior Vice President
• Pamela J Pure,
  Senior Vice President
• Robert W Matschullat,
  Director
• Paul E Kirincic,
  SVP, Human Resources
• Carl E Reichardt,
  Director
• Tully M Friedman,
  Director
• David M Lawrence,
  Director
• Alton F Iii Irby,
  Director
• Randall N Spratt,
  EVP, CIO
• Jane E Shaw,
  Director
• Laureen Seeger,
  EVP,Gen. Counsel & Secretary
• Jeffrey C Campbell,
  EVP, Chief Financial Officer
• Nancy Avila,
  EVP, CIO & CTO
• Thomas L Rodgers,
  EVP, Chief Strategy & BDO
• Richard H Carmona,
  Director
• Kevin Emerson,
  SVP, Controller & CAO
• Napoleon B Jr Rutledge,
  SVP, Controller & CAO
• Deborah Dunsire,
  Director